Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Guggenheim analyst Seamus Fernandez initiated coverage on Cidara Therapeutics, Inc. (NASDAQ:CDTX) with a Buy rating and announced a price target of $33. Cidara Therapeutics shares closed at $13.11 on Thursday. See how other analysts view this stock.
RBC Capital analyst Leonid Timashev initiated coverage on Cytokinetics, Incorporated (NASDAQ:CYTK) with an Outperform rating and announced a price target of $80. Cytokinetics shares closed at $55.84 on Thursday. See how other analysts view this stock.
Stephens & Co. analyst Sudan Loganathan initiated coverage on Immunome, Inc. (NASDAQ:IMNM) with an Overweight rating and announced a price target of $30. Immunome shares closed at $12.54 on Thursday. See how other analysts view this stock.
Jefferies analyst Dennis Ding initiated coverage on Inhibikase Therapeutics, Inc. (NASDAQ:IKT) with a Buy rating and announced a price target of $8. Inhibikase Therapeutics shares closed at $2.78 on Thursday. See how other analysts view this stock.
UBS analyst Ben Shelley initiated coverage on Flutter Entertainment plc (NYSE:FLUT) with a Buy rating and announced a price target of $306. Flutter Entertainment shares closed at $237.98 on Thursday. See how other analysts view this stock.
Considering buying CYTK stock? Here’s what analysts think:
